Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX4V8M
|
||||
Drug Name |
1-(4-Methoxyphenyl)-6,7-methylenedioxy-2-(4-methylthiophenyl-ureido)-2H-isoquinolin-3-one
|
||||
Synonyms |
CHEMBL596265
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C25H21N3O5S
|
||||
Canonical SMILES |
COc1ccc(cc1)C2=C3C=C4OCOC4=CC3=CC(=O)N2NC(=O)Nc5ccc(SC)cc5
|
||||
InChI |
InChI=1S/C25H21N3O5S/c1-31-18-7-3-15(4-8-18)24-20-13-22-21(32-14-33-22)11-16(20)12-23(29)28(24)27-25(30)26-17-5-9-19(34-2)10-6-17/h3-13H,14H2,1-2H3,(H2,26,27,30)
|
||||
InChIKey |
KDCNFQOPLAMXSF-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin L | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Endosomal/Vacuolar pathway | ||||
Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
MHC class II antigen presentation | |||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.